Cost-Effectiveness of Percutaneous Coronary Intervention Compared With Medical Therapy for Ischemic Heart Disease in Japan
Cost-Effectiveness of Percutaneous Coronary Intervention Compared With Medical Therapy for Ischemic Heart Disease in Japan
复制标题
DOI：
10.1253/circj.cj-19-0148
复制
发表时间：
2019-07-01
影响因子：
3.3
通讯作者：
Komuro, Issei
中科院分区：
文献类型：
--
作者：
Kodera, Satoshi;Morita, Hiroyuki;Komuro, Issei
背景：在日本，经皮冠状动脉介入治疗（PCI）治疗缺血性心脏病的成本效益尚未确定。本研究的目的是分析PCI的成本效益与药物治疗ST段抬高型心肌梗死（STEMI）和心绞痛（AP）相比，在Japanes.Methods和Results：我们使用马尔可夫模型STEMI和AP评估的成本和效益与PCI或药物治疗从卫生系统的角度来看。我们估计了增量成本效果比（ICER），以质量调整生命年（QALY）表示，
Background: The cost-effectiveness of percutaneous coronary intervention (PCI) for ischemic heart disease is undetermined in Japan. The aim of this study was to analyze the cost-effectiveness of PCI compared with medical therapy for ST-elevation myocardial infarction (STEMI) and angina pectoris (AP) in Japan.Methods and Results: We used Markov models for STEMI and AP to assess the costs and benefits associated with PCI or medical therapy from a health system perspective. We estimated the incremental cost-effectiveness ratio (ICER), expressed as quality-adjusted life-years (QALY), and ICER